Literature DB >> 4698929

A new prognostic score and clinical evaluation system for cystic fibrosis.

L M Taussig, J Kattwinkel, W T Friedewald, P A Di Sant'Agnese.   

Abstract

Entities:  

Mesh：

Year:  1973        PMID： 4698929     DOI： 10.1016/s0022-3476(73)80110-6

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  47 in total

1.  The reliability of cost-utility estimates in cost-per-QALY league tables .

Authors:  S Petrou; M Malek; P G Davey
Journal:  Pharmacoeconomics       Date:  1993-05       Impact factor: 4.981

2.  Attendance allowance.

Authors:  S A Peters; C J Rolles
Journal:  BMJ       Date:  1991-04-20

3.  Bone changes associated with cystic fibrosis.

Authors:  R N Lipnick; R B Glass
Journal:  Skeletal Radiol       Date:  1992       Impact factor: 2.199

4.  Persistence mechanisms in Pseudomonas aeruginosa from cystic fibrosis patients undergoing ciprofloxacin therapy.

Authors:  J M Diver; T Schollaardt; H R Rabin; C Thorson; L E Bryan
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

Review 5.  Pharmacokinetics of drugs in cystic fibrosis.

Authors:  M Spino
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

6.  Year-to-year changes in lung function in individuals with cystic fibrosis.

Authors:  Theodore G Liou; Eric P Elkin; David J Pasta; Joan R Jacobs; Michael W Konstan; Wayne J Morgan; Jeffrey S Wagener
Journal:  J Cyst Fibros       Date:  2010-05-14       Impact factor: 5.482

7.  Recovery of Pseudomonas gladioli from respiratory tract specimens of patients with cystic fibrosis.

Authors:  J C Christenson; D F Welch; G Mukwaya; M J Muszynski; R E Weaver; D J Brenner
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

8.  Relationships between essential fatty acid levels, pulmonary function and fat absorption in pre-adolescent cystic fibrosis children with good clinical scores.

Authors:  G N Thompson
Journal:  Eur J Pediatr       Date:  1989-01       Impact factor: 3.183

9.  Absorption of safflower oil and structured lipid preparations in patients with cystic fibrosis.

Authors:  V S Hubbard; M C McKenna
Journal:  Lipids       Date:  1987-06       Impact factor: 1.880

10.  Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial.

Authors:  Antoinette Moran; Penelope Pekow; Patricia Grover; Martha Zorn; Bonnie Slovis; Joseph Pilewski; Elizabeth Tullis; Theodore G Liou; Holley Allen
Journal:  Diabetes Care       Date:  2009-07-10       Impact factor: 17.152
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.